anmelden
SPI
18.826,51
PKT
+347,91
PKT
+1,88
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.12.12 | Holcim neutral | Citigroup Corp. | |
| 17.12.12 | Holcim buy | Citigroup Corp. | |
| 17.12.12 | Lonza hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.12.12 | Holcim hold | Vontobel Research | |
| 14.12.12 | Partners Group kaufen | Sarasin Research | |
| 14.12.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 14.12.12 | Helvetia Baloise hold | Vontobel Research | |
| 14.12.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 14.12.12 | Zurich Insurance outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 13.12.12 | Sika neutral | Sarasin Research | |
| 13.12.12 | Barry Callebaut reduce | Sarasin Research | |
| 13.12.12 | ALSO hold | Vontobel Research | |
| 13.12.12 | Sika hold | Vontobel Research | |
| 13.12.12 | Barry Callebaut hold | Vontobel Research | |
| 12.12.12 | Swatch (I) buy | Nomura | |
| 12.12.12 | Roche outperform | Credit Suisse Group | |
| 12.12.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 12.12.12 | Roche buy | Deutsche Bank AG | |
| 12.12.12 | Barry Callebaut neutral | Sarasin Research | |
| 11.12.12 | Tecan (N) buy | UBS AG | |
| 11.12.12 | Swiss Life buy | Sarasin Research | |
| 11.12.12 | Schweiter buy | UBS AG | |
| 11.12.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Roche outperform | Exane-BNP Paribas SA | |
| 11.12.12 | UBS outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Adecco SA buy | Deutsche Bank AG | |
| 11.12.12 | Roche halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 11.12.12 | Novartis reduce | Vontobel Research | |
| 11.12.12 | Arbonia hold | Vontobel Research | |
| 11.12.12 | Schweiter hold | Vontobel Research | |
| 10.12.12 | UBS neutral | Exane-BNP Paribas SA | |
| 10.12.12 | Straumann kaufen | Die Actien-Börse | |
| 10.12.12 | TX Group hold | Vontobel Research | |
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove |